BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 28
• 29
• 30

• Deals

  OSI Pharmaceuticals, Inc. Completes Its Acquisition Of Eyetech Pharmaceuticals, Inc.

  November 14, 2005

   · 

  1 min read
• Drug Development

  FibroGen, Inc. Provides Update On The Development Of FG-2216 And FG-4592, Oral Therapies For Anemia

  November 14, 2005

   · 

  1 min read
• Drug Development

  RenaMed Biologics, Inc. Reports Positive Phase II Data With Renal Bio-Replacement Therapy

  November 14, 2005

   · 

  1 min read
• Business

  DNAPrint Genomics Inc. And SeraCare Life Sciences, Inc. Collaborative Combine To Improve Outcome For Ovarian Cancer Treatment

  November 14, 2005

   · 

  1 min read
• Pharm Country

  SAFE-BioPharma, LLC CEO To Present At The National Healthcare CFO & CIO Summit 2005

  November 14, 2005

   · 

  1 min read
• Mistral Pharma Inc. To Present At BioFinance 2005

  November 14, 2005

   · 

  1 min read
• FDA

  CardioGenesis Receives CE Mark Approval To Market Minimally Invasive Platform In European Union

  November 14, 2005

   · 

  5 min read
• Drug Development

  Vasogen ACCLAIM Phase 3 Trial In Advanced Chronic Heart Failure Reaches Target Number Of Endpoint Events

  November 14, 2005

   · 

  5 min read
• Drug Development

  Shire Pharmaceuticals Group plc Release: New Six-year Data Supports FOSRENOL(R) As A Treatment Choice For End-Stage Renal Disease Patients

  November 14, 2005

   · 

  11 min read
• Drug Development

  Oncolytics Biotech Inc. To Webcast Clinical Trial Update For REOLYSIN(R)

  November 14, 2005

   · 

  3 min read